Back

CKII-Phosphorylated HPV-16 E7 Disrupts Planar Cell Polarity by Recruiting Vangl1

Gbala, I. D.; Basukala, O.; Myers, M. P.; Bertolio, R.; Del Sal, G.; Banks, L.

2026-02-26 cancer biology
10.64898/2026.02.25.707969 bioRxiv
Show abstract

High-risk human papillomaviruses (HPVs) depend on continuous expression of the E6 and E7 oncoproteins to sustain malignant transformation. The high-risk E7 oncoprotein is multifunctional, and its phosphorylation by Casein Kinase II (CKII) amplifies its oncogenic potential. Here, we identify Vangl1, a core planar cell polarity (PCP) scaffold protein, as a novel, phosphorylation-dependent interactor of HPV-16 E7. CKII-mediated phosphorylation is required for Vangl1 recruitment, and this interaction is largely selective for HPV-16 E7. In cervical cancer cells, E7 expression profoundly disrupts Vangl1 homeostasis, producing a biphasic proteostatic imbalance in which phosphorylated Vangl1 is aberrantly retained. This retention parallels E7 stability, revealing a reciprocal oncogenic stabilization. E7 also impairs Vangl1 trafficking and localization by co-opting the clathrin adaptor subunit AP1M1. Functionally, Vangl1 depletion mirrors E6/E7 loss in CaSki spheroids by disrupting spheroid architecture, reducing invasiveness, and increasing chemosensitivity. Taken together, these findings position Vangl1 as a central effector in E7-mediated cervical transformation and invasive progression. TeaserE7s control of Vangl1 reveals a polarity-remodeling mechanism that drives cervical cancer invasion and progression.

Matching journals

The top 8 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.